Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Schizophrenia Animation – Medical Animation

3d medical illustrations

Schizophrenia method of action videos custom MOA's.  Hallucination animations medical animated delusions.  Medical animation studio 3d medical simulations and medical device simulations.  Tres 3d top medical animation company.
Dr Nano
Neural pathway identified that controls attention has implications for psychiatric disorders
The next time you are in a crowded room, or a meeting, or even at the park with your kids, take a look around. How many people are on their phone? Distractions invade every aspect of our lives.
Discovery of novel drug target may lead to better treatment for schizophrenia
Scientists at the Centre for Addiction and Mental Health (CAMH) have identified a novel drug target that could lead to the development of better antipsychotic medications.Dr.
Study is first to investigate rate of HIV testing in patients with specific mental illnesses
People with mental illness are more likely to have been tested for HIV than those without mental illness, according to a new study from a team of researchers at Penn Medicine and the U.S.
Medications for patients with first episode psychosis may not meet guidelines
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found.
Experts conclude that hallucinations and delusions are common and understandable
A report published by the British Psychological Society's Division of Clinical Psychology challenges received wisdom about the nature of mental illness.
Excess protein during brain development causes abnormalities and faulty connections in laboratory studies, may trigger schizophrenia
A gene associated with schizophrenia plays a role in brain development and may help to explain the biological process of the disease, according to new Rutgers research.
Brain network vulnerable to Alzheimer's and schizophrenia identified
A specific brain network within grey matter develops later than the rest of the brain and degenerates first in older age, says new study, shedding light on neurological disorders.
Help for schizophrenia patients and their caregivers
University of Miami researchers are developing a novel, culturally informed, family therapy for schizophreniaResearchers at the University of Miami (UM) have developed a family-focused...
New real-world data highlight health and financial impact of caring for an adult with schizophrenia
Data presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress, Amsterdam, The Netherlands, reveal that caregivers of adults with...
Robot may explain some symptoms in schizophrenia and other neurological conditions
People don't really tend to see ghosts or guardian angels as much as "feel" them, and now researchers reporting in the Cell Press journal Current Biology think they know where that "feeling of a...
Better gauging the reactions of sex offenders and assessing their therapeutic progress via virtual reality
Virtual reality may be the key to predicting both the behaviour of sex offenders and the effectiveness of the therapies they have undergone, according to a study undertaken by Massil Benbouriche of...
A fifth of schizophrenia cases 'may be attributable to T. gondii infection'
A researcher from the University of Pennsylvania calculates that Toxoplasma gondii - a parasite that causes toxoplasmosis - may be involved in more than 20% of schizophrenia cases.
EEG test to help understand and treat schizophrenia
Researchers at University of California, San Diego School of Medicine have validated an EEG test to study and treat schizophrenia.
Engineered cells reveal changes associated with learning, memory and reward
Scientists have created cells with fluorescent dyes that change color in response to specific neurochemicals.
Schizophrenia: data supporting the efficacy, safety and tolerability of once-daily Latuda® (lurasidone) presented at ECNP 2014
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. presented new evidence supporting the use of Latuda® (lurasidone), an atypical antipsychotic treatment for adults...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2014
Content Management / Website Design by Tresware